You searched for metabolic diseases - Page 55 of 62

News and Trends 17 Oct 2017

Genfit Gets €180M Cash Injection to Bring its Pipeline to Market

…therapeutics for metabolic and inflammatory diseases. Its lead candidate, elafibranor, targets Non-Alcoholic Stato-Hepatitis (NASH) – an inflammatory disease of the liver. The company has raised €180M by selling bonds that…

October 17, 2017 - 3 minutesmins - By Alex Dale

News and Trends 1 Oct 2018

Cancer-Sniffing Diagnostics Company Secures €43.1M Funding

…other diseases such as tuberculosis, asthma, and inflammatory bowel disease. For example, GSK showed interest in the device last year, using it in a clinical trial of its treatment for…

October 1, 2018 - 2 minutesmins - By Jonathan Smith

More News! 21 Dec 2022

Watch: Aphaia Pharma interview

…metabolic disorders such as obesity and associated diseases. Aphaia Pharma’s lead candidate, APH-012, a glucose formulation, has been shown to safely restore endogenous hormone release in individuals with obesity. APH-012…

December 21, 2022 - 1 minutemin - By Jim Cornall

News and Trends 3 Apr 2020

Lilly Partners UK Immunometabolism Biotech in Deal Worth €811M

…cell growth through targeting metabolic pathways has the potential to deliver new approaches to treat a wide range of severe diseases.” The UK company has only shared minimal information about…

April 3, 2020 - 2 minutesmins - By Helen Albert

News and Trends 7 Oct 2016

Meet the ‘Haut-Couturiers’ of Bioengineering

…and deletion of genes and the modification of metabolic pathways in bacterial strains and yeasts, enabling the development of efficient bioproduction systems. The great innovation of this site-specific technology is…

October 7, 2016 - 3 minutesmins - By Jerome Topsent

News and Trends 6 Dec 2022

Avalon BioVentures to invest in early-stage biotech

…50 biotech and health tech companies. Portfolio companies have advanced drug candidates across a broad range of disease indications including cancer, celiac disease, infectious disease, metabolic disease, neurodegeneration, and rare…

December 6, 2022 - 2 minutesmins - By Jim Cornall

tumor cancer immunotherapy alderaan biotech

News and Trends 17 Jun 2020

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug

…in cancer as well as other diseases such as malaria and metabolic conditions. One of the most advanced oncology biotechs targeting this same protein is US-based Vigeo Therapeutics, whose lead…

June 17, 2020 - 2 minutesmins - By Victor Kotsev

News and Trends 1 Feb 2023

Advancing cancer care with 3D genomics

…types, including genomic, epigenomic, transcriptomic, proteomic, and metabolic profiles. It relies on the belief that subsequent machine learning data analyses will capture meaningful insights from this data, despite there often…

February 1, 2023 - 7 minutesmins - By External Contributor

In Depth 20 Mar 2024

Are molecular glues the key to undruggable targets?

…coined more than three decades ago, and its potential impact in treating diseases has been realized for a while now, however, developing them has proven to be quite challenging. This…

March 20, 2024 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 21 Apr 2017

The World’s Most Expensive Drugs have European Owners

A new report has listed the world’s most expensive drugs. Not surprisingly, those targeting rare diseases bear the heaviest price tags – let’s have a look. While biotechs like Généthon…

April 21, 2017 - 4 minutesmins - By Melanie De Almeida

News and Trends 8 Nov 2022

Rallybio announces positive phase 1 results for drug treating PNH and gMG

…diseases. Since its launch in January 2018, it has built a portfolio of promising product candidates, which are now in development to address rare diseases in the areas of hematology,…

November 8, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 28 Aug 2024

GLP-1 shortage: Can biotech companies keep up with rising demand?

…added Patrik Jonsson, executive vice president, and president of Lilly Cardiometabolic Health and Lilly USA, in a press release. Moreover, Lilly’s main contender, the Danish multinational Novo Nordisk, is investing…

August 28, 2024 - 6 minutesmins - By Roohi Mariam Peter

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Genfit Gets €180M Cash Injection to Bring its Pipeline to Market

Cancer-Sniffing Diagnostics Company Secures €43.1M Funding

Watch: Aphaia Pharma interview

Lilly Partners UK Immunometabolism Biotech in Deal Worth €811M

Meet the ‘Haut-Couturiers’ of Bioengineering

Avalon BioVentures to invest in early-stage biotech

€30M Series A to Fund Spanish Biotech’s Anti-Metastasis Cancer Drug

Advancing cancer care with 3D genomics

Are molecular glues the key to undruggable targets?

The World’s Most Expensive Drugs have European Owners

Rallybio announces positive phase 1 results for drug treating PNH and gMG

GLP-1 shortage: Can biotech companies keep up with rising demand?

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!